Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Cloxacillin Benzathine
Vetoquinol Ireland Limited
QJ51CF02
Cloxacillin Benzathine
600 milligram(s)
Intramammary suspension
POM: Prescription Only Medicine as defined in relevant national legislation
cloxacillin
Authorised
2021-04-23
Health Products Regulatory Authority 23 April 2021 CRN009FKH Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT PERMAWAY 600 mg intramammary suspension for cattle 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each intramammary syringe (3.6 g) contains: ACTIVE SUBSTANCE: Cloxacillin (as benzathine) 600 mg EXCIPIENTS: For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Intramammary suspension. Shiny white to off-white viscous suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dairy cattle (dry cows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of subclinical mastitis at dry-off and prevention of new intramammary infections occurring during the dry period, caused by _Trueperella pyogenes, Staphylococcus spp., Streptococcus agalatiae, Streptococcus dysgalactiae _and_ _ _Streptococcus uberis_, susceptible to cloxacillin. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to penicillins, cephalosporins, or to any of the excipients. Do not use in cows with clinical mastitis outside the dry period. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE This product does not contain any antimicrobial preservatives. Special precautions for use in animals Use of the product should be based on susceptibility testing of bacteria isolated from milk samples obtained from the udder quarter(s) of each cow to be dried off. If this is not possible, therapy should be based on local (regional, farm level) risk based epidemiological information about the expected pathogen challenge, and susceptibility of target bacteria. Use of the product deviating from the instructions given in the SPC may contribute to the development of bacterial resistance to cloxacillin which may also decrease the effectiveness of treatment with other beta-lactamase resistant penicillins. Dry cow therapy protocols should take local and national policies on antimicrobial use into consideration, and undergo regular veterinary review. Les hele dokumentet